ArticlePLOS digital health2026
Strategies for integrating artificial intelligence and cognitive assessment to predict disability progression in relapsing-remitting multiple sclerosis: A model development study.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Serial cognitive assessment in multiple sclerosis can help identify patients at higher risk of disability progression, but high dimensionality of reaction-time data makes analysis challenging. We developed a method to convert longitudinal reaction-time data into images and applied deep survival modelling to predict disability progression in relapsing-remitting MS (RRMS). In this cohort study, clinical data were obtained from the MSBase registry and cognitive data from the MSReactor computerised cognitive battery between February 2016 and September 2022, with a median follow-up of 3.2 years. The serial reaction-time data from three tasks (psychomotor function [R], attention [G], and working memory [B]) were converted into multicolour images using RGB encoding. We extracted the key features from the images using a convolutional neural network and combined them with clinical variables in a Transformer-based survival model (MS-TranSurv) to predict time to confirmed disability progression. Discrimination, calibration, and accuracy were assessed using the C-index, integrated Brier score (iBS), and time-dependent area under the receiver operating characteristic (tAUROC). Performance was compared with other machine learning models, including Dynamic DeepHit, Recurrent Deep Survival Machines, a Cox proportional hazards model in traditional statistics using clinical variables only, and a version of MS-TransSurv using mean test values. A total of 746 RRMS patients were included. MS-TranSurv showed slightly higher discrimination compared with benchmark models, with a C-index of 0.61 (95% CI 0.54-0.68) and tAUROC of 0.74 (95% CI 0.63-0.85), as well as comparable calibration, with an iBS of 0.24 (95% CI 0.16-0.32). Using individual test-level data provided slightly better performance than using summary measures. Longitudinal cognitive reaction-time data can be used for survival-based prediction of disability progression in RRMS. This framework supports remote cognitive monitoring and may improve risk stratification and clinical trial enrichment, with potential applicability to other high-dimensional digital biomarkers.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.